课题基金 / 基金详情

DEFINING PHENOTYPIC TRAITS IN OBSTRUCTIVE SLEEP APNEA

DEFINING PHENOTYPIC TRAITS IN OBSTRUCTIVE SLEEP APNEA
定义阻塞性睡眠呼吸暂停的表型特征
批准号:
7718915
负责人:
DAVID ANDREW WELLMAN
金额:
$1.32万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2008-05-31

项目摘要

项目成果

DAVID ANDREW WELLMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. In this study, the aim is to define the relative contribution of the following variables to both apnea presence and severity in a group of individuals with a wide range of respiratory disturbance index (RDI): a) pharyngeal anatomy (MRI and Pcrit), b) pharyngeal dilator muscle responsiveness to increasing mechanical load during NREM sleep, c) ventilatory control stability (loop gain), d) arousal threshold. These variables will be modeled as predictors of apnea severity in each individual to define the different apnea phenotypes. It is hypothesized that there will be five or six groupings of the phenotypic traits (cluster analysis) that will either cause obstructive sleep apnea or prevent its development. This proposal also aims to determine if apnea phenotype predicts responsiveness to certain forms of therapy: 1) Does oxygen administration or acetazolamide, both of which stabilize the control of breathing, improve sleep apnea in patients with unstable ventilatory control (high loop gain)? 2) Does sedative administration, such as Trazodone, improve sleep apnea in patients identified as having a low arousal threshold (i.e. awaken easily from sleep, which would make breathing more variable and promote sleep apnea)?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
  • 批准号:
    10440108
  • 项目类别:
  • 资助金额:
    $81.62万
  • 财政年份:
    2022
  • 负责人:
    DAVID ANDREW WELLMAN
  • 依托单位:
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
  • 批准号:
    10705062
  • 项目类别:
  • 资助金额:
    $79.65万
  • 财政年份:
    2022
  • 负责人:
    DAVID ANDREW WELLMAN
  • 依托单位:
Project 5
Project 5
海外基金